Results 31 to 40 of about 10,563 (168)

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients

open access: yesHaematologica, 2021
Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) can induce long-term remissions in patients with chronic lymphocytic leukemia.
Johannes Bloehdorn   +15 more
doaj   +1 more source

Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib [PDF]

open access: yes, 2017
Monitoring of single cell signal transduction in leukemic cellular subsets has been proposed to provide deeper understanding of disease biology and prognosis, but has so far not been tested in a clinical trial of targeted therapy. We developed a complete
Dumrese, Claudia   +28 more
core   +4 more sources

Long term post PrePex male circumcision outcomes in an urban population in Uganda: a cohort study

open access: yesBMC Research Notes, 2017
Objective The objective of this study was to determine the long term adverse events profile at least a year after safe male circumcision. Results A cohort study, investigating patients who had undergone a non surgical circumcision procedure called Prepex.
M. Galukande   +5 more
doaj   +1 more source

Learning curve for minimally invasive oesophagectomy of oesophageal cancer and survival analysis

open access: yesJournal of Cardiothoracic Surgery, 2021
Purpose Minimally invasive oesophagectomy is a technically demanding procedure, and the learning curve for this procedure should be explored. A survival analysis should also be performed.
Yunpeng Zhao   +4 more
doaj   +1 more source

The impact of approaches in improving male partner involvement in the prevention of mother-to-child transmission of HIV on the uptake of maternal antiretroviral therapy among HIV-seropositive pregnant women in sub-Saharan Africa: a systematic review and meta-analysis. [PDF]

open access: yes, 2017
Objectives: To identify the approaches that are used in improving on male partner involvement in the prevention of mother-to-child transmission (PMTCT) of HIV and their impact on the uptake maternal antiretroviral therapy (ART) in sub-Saharan Africa (SSA)
Johnman, Cathy   +2 more
core   +1 more source

Quality and Publication of Emergency Medicine Trials Registered in ClinicalTrials.gov [PDF]

open access: yes, 2020
Introduction: Promoting emergency medicine (EM) clinical trials research remains a priority. To characterize the status of clinical EM research, this study assessed trial quality, funding source, and publication of EM clinical trials and compared EM and ...
Calvocoressi, Lisa   +7 more
core  

Trial discontinuation: lessons for future trial design? [PDF]

open access: yes, 2012
Background: The current therapeutic arsenal still does not fulfill the therapeutic needs of inflammatory bowel disease patients. Although new drugs are constantly being developed, many will never reach the market.
Haar, C.J. (Colin) de   +2 more
core   +1 more source

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

open access: yesHaematologica, 2023
Chemoimmunotherapy followed by consolidative high-dose therapy with autologous stem cell rescue was a standard upfront treatment for fit patients with mantle cell lymphoma (MCL) in first remission; however, treatment paradigms are evolving in the era of
Zachary D. Epstein-Peterson   +23 more
doaj   +1 more source

Protocol for a systematic scoping review of reasons given to justify the performance of randomised controlled trials. [PDF]

open access: yes, 2019
IntroductionRandomised controlled trials (RCTs) are widely viewed to generate the most reliable medical knowledge. However, RCTs are not always scientifically necessary and therefore not always ethical.
Chevrier, Stephanie   +7 more
core   +2 more sources

Study protocol for THINK : a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types [PDF]

open access: yes, 2017
Introduction: NKR-2 are autologous T cells genetically modified to express a chimeric antigen receptor (CAR) comprising a fusion of the natural killer group 2D (NKG2D) receptor with the CD3 zeta signalling domain, which associates with the adaptor ...
Aftimos, Philippe   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy